alexa
Reach Us +44-1522440391
Interview | Mojtaba AkhtarinbspChemotherapy Open Access
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Mojtaba Akhtari
Mojtaba Akhtari

Executive Editor
Mojtaba Akhtari
Division of Hematology and Oncology
University of Nebraska Medical Center
Omaha, USA
Tel. 402-559-3834
Fax. 402-559-6520
Read Interview session with Mojtaba Akhtari

 
Biography

Dr. Mojtaba Akhtari is an Assistant Professor in the Department of Internal Medicine, Division of Hematology and Oncology at the University of Nebraska Medical Center. He earned his medical degree from Tehran University of Medical Sciences in Tehran, Iran. Then, he moved to England, where he received training in internal medicine and hematology. He served in the Department of Hematological Medicine, King’s College Hospital in London, England. He moved to Evanston, Illinois, USA, where he completed his residency in internal medicine at Saint Francis Hospital of Evanston, and he also received Humanism in Medicine Award. He undertook fellowship training in hematology and medical oncology at Winship Cancer Institute, Emory University School of Medicine in Atlanta, Georgia, and during this time he specialized in the management of benign and malignant hematological disorders, stem cell transplantation, and solid tumors. He is board certified in Internal medicine, Hematology and Medical Oncology. He is an active member of the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO) and American Society for Blood and Marrow Transplantation (ASBMT). Dr. Akhtari is a member of the Chronic Myeloid Leukemia Panel of the National Comprehensive Cancer Network (NCCN).

 
Research Interest

Acute and chronic leukemias as well as myelodysplastic syndromes, therapy-related myeloid neoplasms, familial leukemias, immune cytopenias, and bone marrow transplantation.

Interview
Top